v3.22.2.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 8,216 $ 8,169 $ 26,900 $ 22,575
General and administrative 3,562 3,394 10,937 9,845
Total operating expenses 11,778 11,563 37,837 32,420
Loss from operations (11,778) (11,563) (37,837) (32,420)
Other income:        
Interest income 351 3 554 19
Net loss (11,427) (11,560) (37,283) (32,401)
Other comprehensive income:        
Net unrealized (loss) gain on available-for-sale investments, net of tax 40 (1) (209) (6)
Net comprehensive loss $ (11,387) $ (11,561) $ (37,492) $ (32,407)
Net loss per share of voting and non-voting common stock, basic $ (0.39) $ (0.45) $ (1.29) $ (1.31)
Net loss per share of voting and non-voting common stock, diluted $ (0.39) $ (0.45) $ (1.29) $ (1.31)

Source